Accelerating NGS analysis at ESHG 2021
Congenica content from ESHG including accelerating NGS analysis satellite session and posters on skeletal dysplasia and automation in a rare disease lab.
Automating Clinical Genomic Analysis & Reporting for Rapid NGS Results
With the increasing access to exome and genome testing the interpretation of this data is taking longer and longer.
Congenica signs distribution agreement with ATC Healthcare in Turkey
Congenica announces new distribution agreement with ATC Healthcare, a Turkish business investing in advanced tech in molecular diagnosis & life sciences.
Living with a rare disease in perspective: Lynsey’s Rare Journey
Lynsey Chediak is on Congenica’s PAE Advisory Board and Head of Partnerships at Rarebase. She also lives with a rare, genetic joint disease arthrogryposis.
Science, genomics hope and a father's love
Congenica’s PAE Lead Charles Steward is guest on ‘Making our Way’ podcast, a place for conversations about some of the toughest and best moments in life.
Congenica contributes to the BIA's Genomics Nation report
Congenica joins the BIA's report looking at the strength, breadth and opportunity of the UK genomics sector for investors, patients and the economy.
Unleash Molecular Superpowers with Next-Generation Genomic Analysis
NGS data analysis software augments molecular medicine powers so more patients can be diagnosed and treated
How we learnt about Menkes Syndrome
For our latest patient guest blog, we welcome Daniel DeFabio, Co-Founder of DISORDER: The Rare Disease Film Festival. Daniel and his wife Tina lost their eldest son Lucas when he was 11 years old to ...
Congenica Receives CE Mark for Genomic Analysis Software
Congenica NGS data analysis software for genomic data interpretation is now CE marked under the In Vitro Diagnostics Directive.
Discovering Glut1 Deficiency Syndrome
In recognition of the first International Glut1 Awareness Day, guest blogger Trudy Morgan from Glut1 Deficiency UK talks about her experiences.
David Atkins welcomes the Government's Life Sciences Sector Vision
A press release from the UK Bio Industry Association (BIA) welcomes the Government's new Life Sciences Sector Vision and quotes Congenica CEO David Atkins
Diagnosing CALFAN syndrome after years of uncertainty
How clinicians used Congenica to diagnose an exceptionally rare condition, providing a diagnosis for a child's medical issues after years of investigation.